Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 402

    1.

    The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults.

    Lévesque LE, Brophy JM, Zhang B.

    Ann Intern Med. 2005 Apr 5;142(7):481-9.PMID: 15809459 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.

    Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J.

    Circulation. 2004 May 4;109(17):2068-73. Epub 2004 Apr 19.PMID: 15096449 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction.

    Brophy JM, Lévesque LE, Zhang B.

    Heart. 2007 Feb;93(2):189-94. Epub 2006 Jul 18.PMID: 16849374 [PubMed - indexed for MEDLINE]Related articles

    4.

    Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction.

    Kimmel SE, Berlin JA, Reilly M, Jaskowiak J, Kishel L, Chittams J, Strom BL.

    Ann Intern Med. 2005 Feb 1;142(3):157-64.PMID: 15684203 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors.

    Lévesque LE, Brophy JM, Zhang B.

    CMAJ. 2006 May 23;174(11):1563-9. Epub 2006 May 2.PMID: 16670396 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.

    Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Nørgård B, Friis S, Sørensen HT.

    Arch Intern Med. 2005 May 9;165(9):978-84.PMID: 15883235 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.

    García Rodríguez LA, Varas-Lorenzo C, Maguire A, González-Pérez A.

    Circulation. 2004 Jun 22;109(24):3000-6. Epub 2004 Jun 14.PMID: 15197149 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Summaries for patients. Risk for heart attacks with different NSAIDs.

    [No authors listed]

    Ann Intern Med. 2005 Apr 5;142(7):I45. No abstract available. PMID: 15809454 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction.

    Andersohn F, Suissa S, Garbe E.

    Circulation. 2006 Apr 25;113(16):1950-7. Epub 2006 Apr 17.PMID: 16618816 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.

    Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.

    Health Technol Assess. 2008 Apr;12(11):1-278, iii. Review.PMID: 18405470 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.

    Gislason GH, Jacobsen S, Rasmussen JN, Rasmussen S, Buch P, Friberg J, Schramm TK, Abildstrom SZ, Køber L, Madsen M, Torp-Pedersen C.

    Circulation. 2006 Jun 27;113(25):2906-13. Epub 2006 Jun 19.PMID: 16785336 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.

    Zhao SZ, Burke TA, Whelton A, von Allmen H, Henderson SC.

    Am J Manag Care. 2002 Oct;8(15 Suppl):S414-27.PMID: 12416791 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.

    Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S.

    Arthritis Rheum. 2006 May;54(5):1378-89.PMID: 16645966 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction.

    Hernández-Díaz S, Varas-Lorenzo C, García Rodríguez LA.

    Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):266-74.PMID: 16611201 [PubMed - indexed for MEDLINE]Related articles

    16.

    Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.

    Rahme E, Watson DJ, Kong SX, Toubouti Y, LeLorier J.

    Pharmacoepidemiol Drug Saf. 2007 May;16(5):493-503.PMID: 17086567 [PubMed - indexed for MEDLINE]Related articles

    17.

    Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.

    Zhao SZ, Burke TA, Whelton A, von Allmen H, Henderson SC.

    Am J Manag Care. 2002 Oct;8(15 Suppl):S401-13.PMID: 12416790 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly.

    Mamdani M, Rochon P, Juurlink DN, Anderson GM, Kopp A, Naglie G, Austin PC, Laupacis A.

    Arch Intern Med. 2003 Feb 24;163(4):481-6.PMID: 12588209 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?

    Savage R.

    Drugs Aging. 2005;22(3):185-200. Review.PMID: 15813652 [PubMed - indexed for MEDLINE]Related articles

    20.

    Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.

    Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G, Shoor S, Ray WA.

    Lancet. 2005 Feb 5-11;365(9458):475-81.PMID: 15705456 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data